8az2
From Proteopedia
(Difference between revisions)
| Line 8: | Line 8: | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8az2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8az2 OCA], [https://pdbe.org/8az2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8az2 RCSB], [https://www.ebi.ac.uk/pdbsum/8az2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8az2 ProSAT]</span></td></tr> | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=8az2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=8az2 OCA], [https://pdbe.org/8az2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=8az2 RCSB], [https://www.ebi.ac.uk/pdbsum/8az2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=8az2 ProSAT]</span></td></tr> | ||
</table> | </table> | ||
| - | == Function == | ||
| - | [https://www.uniprot.org/uniprot/IAPP_HUMAN IAPP_HUMAN] Selectively inhibits insulin-stimulated glucose utilization and glycogen deposition in muscle, while not affecting adipocyte glucose metabolism. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Current revision
IAPP S20G growth-phase fibril polymorph 3PF-CU
| |||||||||||
